Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-05-02 @ 3:03 AM
Study NCT ID:
NCT02384967
Status:
COMPLETED
Last Update Posted:
2017-01-24
First Post:
2015-02-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients
Sponsor:
ANRS, Emerging Infectious Diseases
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
ANRS 165 DARULIGHT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None